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Bepridil is an investigational calcium antagonist that bepridil and enflurane was demonstrated in the 
also has fast sodium channel blocking and antidys- following cardiac electrophysiologic parameters: 
rhythmic properties. In the present study, the poten- depression of sinus node function as evidenced by 
tial interactions of bepridil with volatile anesthetics severe depression of sinus node automaticity and 
on cardiac electrophysiologic parameters were eval- conduction; depression of atrioventricular function 
uated in open-chest dogs. Twenty-four dogs anes- as evidenced by prolongation of the atrial-His bundle 
thetized with enflurane (n = 6). halothane (n = 6). interval and the Wenckebach R-R interval: and, pro- 
isoflurane (n = 6). or chloralose (n = 6) received 2.5 longation of the atrial effective refractory period. No 
mg/kg of bepridil intravenously (IV). Twenty-five synergy was demonstrated between bepridil and 
additional dogs anesthetized with enflurane (n = 7). halothane or isoflurane when compared to bepridil’s 
halothane (n = 6). isoflurane (n = 61, or chloralose effects during chloralose anesthesia. It is concluded 
(n = 6). received bepridil, 5.0 mg/kg, IV. Dogs anes- that significant synergistic cardiac electrophysio- 
thetized with cloralose served as controls. Cardiac logic effects exist between bepridil and enflurane in 
electrophysiologic parameters were measured after dogs. It is recommended that caution be used when 
the dogs were anesthetized and were repeated 5, anesthetizing patients receiving bepridil with enflu- 
15. 30, 45, and 60 minutes after bepridil infusion. rane until human data on the use of this combination 
Plasma bepridil concentrations were also deter- of pharmacologic agents is available. 
mined at the above time points. Synergy between 8 1999 by Grune & Stratton, inc. 
B EPRIDIL, a calcium antagonist, has been used extensively in Europe as an antiangi- 
nal agent.lm3 It differs from the calcium antago- 
nists currently available in the United States 
(diltiazem, verapamil, and nifedipine) in several 
ways.4 The half-life of orally administered 
bepridil is 33 + 15 hours, which is considerably 
longer than the half-lives of currently available 
calcium antagonists.‘g6 Bepridil is also known to 
act at the sodium channel, and possibly the 
potassium channel, producing quinidine-like 
effects on the cardiac action potential.7 In elec- 
trophysiologic experiments, bepridil possesses 
both slow calcium and fast sodium channel inhib- 
itory activities, while other electrophysiologic 
studies suggest that it may possess class III 
antidysrhythmic properties.* Bepridil is also 
reported to prevent reperfusion-induced 
tachyarrhythmias and ventricular fibrillation in 
the unanesthetized dog.’ 
It has been suggested that the volatile 
anesthetics, because of their intrinsic calcium 
channel-blocking effects, could interact with 
bepridil resulting in significant cardiovascular 
side-effects.“-” Verapamil and diltiazem have 
potent interactions with enflurane that have not 
been demonstrated with halothane or isoflu- 
rane.13,14 Severe sinus node depression and 
advanced AV nodal block occur when verapamil 
is administered to animals anesthetized with 
enflurane, but not in animals anesthetized with 
halothane or isoflurane.14 
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The cardiac electrophysiologic interactions 
between the volatile anesthetics and two intrave- 
nously (IV) administered doses of bepridil were 
examined in this experiment. Dogs anesthetized 
with chloralose and given the same doses of 
bepridil served as controls for this experiment. 
Because bepridil also possesses class I antidys- 
rhythmic properties, the effects of these interac- 
tions on atria1 and ventricular refractory periods 
were examined, as well as their effects on sinus 
and atrioventricular node function. 
MATERIALS AND METHODS 
0 I988 by Grune & Stratton, Inc. 
0888-6296/88/0203-0012$03.00~0 
Forty-nine mongrel dogs weighing 8 to 15 kg were 
divided into eight groups. Animals in groups 1 (n = 6) and 2 
(n = 6) were given 10 mg of diazepam to prevent seizures, 
induced with 120 mg/kg of IV chloralose, and maintained 
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with 50 mg/kg/h of IV chloralose for the entire experiment. 
Although lower doses of chloralose have been used in the 
past. it was found that the dose used was necessary to ensure 
hemodynamic stability of the model (ie, stable pulse rate and 
blood pressure). Since chloralose has been shown to be an 
anesthetic with minimal effects on cardiac electrophysiologic 
parameters, these animals served as control groups for the 
experiment. Is Animals in groups 3 (n = 6) and 4 (n = 6) 
underwent inhalation induction with halothane and were 
maintained at 1.3% halothane end-tidal concentration 
(MAC = 0.87%) throughout the experiment. Animals in 
grW.ps 5 (n - 6) and 6 (n = 7) underwent inhalation induc- 
tion with enflurane and were maintained at 3.3% enflurane 
(MAC - 2.2%) end-tidal concentration throughout the 
experiment. Animals in groups 7 (n = 6) and 8 (n = 6) 
underwent inhalation induction with isoflurane and were 
mazntained at 2.2% isoflurane (MAC = 1.48%) end-tidal 
concentration throughout the experiment. End-tidal anes- 
thetic concentrations were monitored using a Perkin-Elmer 
Model 1100 medical gas analyzer. 
After induction, femoral arterial and venous catheters 
were inserted. Hydration was maintained during the experi- 
ment by infusion of 1,500 to 2,500 mL of lactated Ringer’s 
solurion. The rate of infusion was adjusted to maintain a 
constant blood pressure in each dog prior to bepridil infusion. 
A quadripolar electrode catheter (interelectrode distance 10 
mrr) was inserted via the right external jugular vein and 
Fig 1. Example of the 
recording8 from which mea- 
sur*nents were made. Each 
traoihg is labeled at the left 
margin. The second tracing is a 
His-bundle IHWtracing and the 
atrial-Hii (AH) and His-Ventric- 
ular {HVl intervals are demon- 
strated. Abbreviations: Atrial. 
atriel electrogram: BP. blood 
Pressure; Stimulus, recording 
of pacing stimuli. 
positioned with the proximal electrode pair in the high right 
atrium to allow atrial pacing while the distal pair recorded 
the atrial electrogram. A bipolar catheter was inserted via the 
left internal carotid artery and advanced into the root of the 
aorta until optimum His-bundle recordings were obtained. 
The heart was exposed through a right thoraeotomy in the 
fifth intercostal space. A bipolar plaque electrode was 
sutured to the mid-right atrium approximately 1.5 cm f:om 
the sinoatrial (SA) node toward the right atrial appendage. 
Another bipolar plaque electrode was sutured to the rrght 
ventricle near its junction with the right atrium, thus ahowing 
the delivery of a second pacing stimulus (S,) to either the 
atrium or the ventricle during atria1 pacing via the tran*ve- 
nous atrial electrode. Plaque electrodes were used to ehmi- 
nate artifactual differences in the measured electrophysio- 
logic parameters that might result from slight changes in the 
position of the transvenous electrode. Determinationr of 
sinoatrial conduction time @ACT) and corrected sinus node 
recovery time (CSNRT) were made during pacing wa the 
proximal pair of electrodes of the transvenous right atria] 
electrode. The atria1 electrogram, ECG, and His-butrdle 
electrogram were continuously displayed using a Tektronix 
oscilloscope while intermittent recordings of these parane- 
ters along with blood pressure were made at designated 
intervals using a Gould ES-1000 recorder with filter settings 
of 40-300 Hz (Fig 1). Measurements of the various inter:als 
were made from these recordings. High right atrial pat,ing 
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and the delivery of atria1 and ventricular S2 stimuli were 
achieved using a Grass S.88 stimulator with the current 
measured and maintained at three times threshold, as deter- 
mined at the beginning of each measurement. Esophageal 
temperature was measured and maintained at 36 to 38°C 
using a Yellow Springs Model 73A temperature controller. 
Arterial blood gases, serum potassium, sodium, calcium, and 
pH were measured periodically and maintained within the 
physiologic range. 
After completion of the surgical preparation, baseline 
measurements of the following parameters were recorded: 
Sinus heart rate, SACT and CSNRT, atrial-His (AH) and 
His-ventricular (HV) intervals at pacing rates of 150, 180, 
and 200 beats/min (bpm), Wenckebach periodicity, and 
atrial and ventricular effective refractory periods at atria1 
pacing rates of 120 bpm. Sinoatrial conduction time was 
measured as described by Narula et aLI High right atria1 
pacing was performed at 5% to 10% above the sinus heart rate 
for eight to ten paced beats and then halted. Sinoatrial 
conduction time was 50% of the difference obtained when the 
prepacing P-P interval was subtracted from the interval 
between the last paced atrial beat and the first sinus escape 
beat on the atrial electrogram. Corrected sinus node recovery 
time was determined by pacing with the high right atria1 
electrode for 30 seconds at heart rates of 150, 180, and 200 
bpm with a one-minute rest period before each pacing 
interval. The first escape beat after the cessation of pacing 
determined the sinus node recovery time, which was defined 
as the interval from the last paced atria1 depolarization to the 
first sinus escape beat measured on the atria1 electrogram. 
The corrected sinus node recovery time was taken as the sinus 
node recovery time interval minus the immediate prepacing 
P-P interval at each pacing rate (150, 180, 200 bpm). The 
highest of these values was recorded as the CSNRT. The AH 
bundle interval and the HV interval were determined at 
paper speeds of 250 mm/s at the rates noted. Wenckebach 
periodicity was obtained by increasing the atria1 pacing rate 
from slightly greater than spontaneous heart rate by 15 to 20 
bpm after even ten paced beats until Wenckebach periodicity 
was observed and recorded. 
Atria1 and ventricular effective refractory periods 
were determined by pacing with the high right atria1 elec- 
trode at a rate of 120 bpm and inserting an extra atrial or 
ventricular stimulus of three times diastolic threshold via the 
plaque electrodes. These extra stimuli were introduced into 
atrial or ventricular diastole with increasing prematurity in 
lo-ms increments each eight to ten atrially paced beats until 
the atrium or ventricle was refractory. The longest atrially 
paced P-S2 or V-S;? intervals without atria1 or ventricular 
capture and the shortest P-S or V-S* intervals with atrial or 
ventricular capture were recorded, and the refractory periods 
taken as the mean of these two values. The above measure- 
ments obtained in each anesthetized dog prior to the adminis- 
tration of bepridil served as the baseline measurements for 
each individual dog. Following the completion of these base- 
line measurements, bepridil, dissolved in 40 mL of 5% 
ethanol, was administered IV over 40 minutes using a Sage 
Model 350 infusion pump. Although faster infusion rates 
have been used by others, r’ it was found to be difficult to 
maintain acceptable blood pressures when these faster infu- 
sion rates were used. Groups 1, 3, 5, and 7 received 2.5 
mg/kg, while groups 2, 4, 6, and 8 received 5.0 mg/kg of 
bepridil. Four additional animals anesthetized with enflu- 
rane, halothane, isoflurane, and chloralose, respectively, were 
given 40 mL of 5% ethanol alone. The electrophysiologic 
measurements noted above were then repeated at 5, 15, 30, 
45, and 60 minutes following the conclusion of the bepridil 
infusion. 
Heparinized 5 mL arterial blood samples were 
obtained at the times noted above and stored in ice until the 
conclusion of the experiment. Following each experiment the 
plasma was separated from each sample using a Backman 
J6B refrigerated centrifuge. The frozen samples were 
shipped to the Department of Drug Metabolism of McNeil 
Pharmaceutical Company, Spring House, PA, where bepridil 
levels were determined by high-performance liquid chroma- 
tography (HPLC) assay.18 
The effects of bepridil were examined in the presence 
of the four anesthetics using paired Student t tests with the 
Bonferroni correction. Differences among anesthetics were 
analyzed using profile analysis and analysis of variance with 
Scheffe corrections for multiple comparisons. When group 
variances were unequal, the nonparametric Kruskal-Wallis 
and median tests were performed.19 
RESULTS 
In animals anesthetized with enflurane, 
heart rate decreased from a baseline rate of 
100 +- 8 bpm to 82 + 6 bpm at the five-minute 
observation following 2.5 mg/kg of bepridil. 
Heart rate was less than 87 bpm during the 
remainder of the observation period in these 
animals. In animals anesthetized with halothane, 
heart rate decreased from a baseline value of 
108 + 10 bpm to a rate of 88 + 8 bpm at the 
five-minute measurement following 2.5 mg/kg 
of bepridil. Heart rate continued to be depressed 
at rates less than 93 bpm throughout the observa- 
tion period. In animals anesthetized with isoflu- 
rane, heart rate decreased from a baseline value 
of 103 f 3 bpm to a rate of 95 k 5 bpm at the 
five-minute measurement following 2.5 mg/kg 
of bepridil. Heart rate returned to levels mea- 
sured prior to bepridil administration at the 
15-minute measurement and remained at this 
rate during the remainder of the observation 
period. All values stated are significant decreases 
(P < .05). In animals anesthetized with chloral- 
ose, the decrease in heart rate reached signifi- 
cance only at the five-minute measurement. 
Heart rate was decreased in all groups of animals 
throughout the observation periods following 5 
mg/kg of bepridil. There were no differences in 
the magnitude of change in heart rate among 
groups of animals anesthetized with enflurane, 
halothane, isoflurane, or chloralose (Fig 2). 
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Fig 2. Serial changes in mean values t SD of heart rate (bpm) show effect of bepridil (5 mglkg). Time 0 reprwts 
control values after induction. Times 5, 15,30,45, and SO represent time periods following bepridil administration. 
Sinoatrial conduction time was unchanged rane (4,640 to 2,460 ms + SD) compared to rhe 
during the observation period in all groups fol- group anesthetized with chloralose (160 to 90 
lowing administration of either the 2.5 or ms * SD) (P < .Ol), while values for the halo- 
5-mg/kg dose of bepridil. There was, however, thane and isoflurane groups were not increased 
wide variability in the SACT following the (Table 2). 
administration of 5 mg/kg of bepridil in the Atrial-His intervals were unchanged rol- 
group of animals anesthetized with enflurane lowing the administration of bepridil, 2.5 mg/kg, 
(Table 1). Animals anesthetized with chloralose, during any of the anesthetics evaluated. This 
halothane, or isoflurane demonstrated no prolon- interval was prolonged following bepridil, 5 mg/ 
gation of CSNRT at either the 2.5-mg/kg or the kg, in animals receiving all anesthetics (Fig 3). 
5-mg/kg dose of bepridil. Mean values of Baseline AH intervals were not different when 
CSNRT exceeded one second at all observation anesthetic groups were compared. Animals anes- 
times in animals anesthetized with enflurane thetized with enflurane and receiving 5 mgJkg of 
receiving 5 mg/kg of bepridil. These values were bepridil demonstrated prolongation of the AH 
increased in the group anesthetized with enflu- interval throughout the 60-minute observation 
Table 1. Bepridil(5 ma/kg) Effect on SACT 
Anesthetic Baseline 5 min 15min 30 min 45 min 60 rni’i 
Chloralose 50 + 24 56 + 26 40 k 8 46+ 13 30 z+ 23 43 i 15 
Halothane 38 + 10 102 11 35 + 9 26 + 7 29 + 7 34 v 12 
tinflurane 7 2 15 50 f 59 440 * 505 362 + 318 5 t 22 14 !? 
lsoflurane 20 k 36 24 + 30 22 i- 33 7 k 32 10 + 34 1 7 3 7 
NOTE. All values are in ms + SD. 
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Table 2. Bepridil (5 mg/kg) Effects on CSNRT 
5 min 15 min 30 min 45 min 60 min 
Chloralose 90 + 20 160 f 40 110 + 30 90 f 20 90 f 20 90 f 30 
Halothane 70+ 10 130 + 20 200 f loo 100 f 20 lOOk 10 9Ok 10 
Enflurane 10 + 60 l 4.640 f 2,2 10 l 4,600 + 1,950 -3.320 + 1,760 l 3.440 f 1.760 ‘2.460 f 1.940 
lsoflurane 130*40 180 + 30 140 f 30 160 f 40 130 f 35 150 f 20 
NOTE. All values are ms + SD. 
l P < .Ol compared to chloralose (Kruskal-Wallis median). 
period. Animals receiving halothane and isoflu- 
rane demonstrated moderate increases in this 
measurement, which maintained significance 
through the 45-minute measurement with halo- 
thane and through the 15-minute measurement 
with isoflurane. Animals receiving chloralose 
demonstrated an increase in the AH interval at 
the five-minute measurement only. Comparison 
of the four groups demonstrated that the AH 
interval was prolonged in animals anesthetized 
with enflurane following administration of 5 
mg/kg of bepridil when compared to animals 
anesthetized with the other anesthetics 
(P < .05). 
Animals anesthetized with enflurane and 
receiving 2.5 mg/kg of bepridil demonstrated an 
increase in the Wenckebach R-R interval 
through 45 minutes of observation when com- 
pared to baseline measurements. This parameter 
also increased in animals anesthetized with halo- 
thane, isoflurane, and chloralose. Animals anes- 
thetized with enflurane and receiving 5 mg/kg of 
bepridil had prolongation of the Wenckebach 
R-R interval throughout the 60-minute observa- 
tion period (P < .Ol). Animals anesthetized with 
chloralose, halothane, and isoflurane while 
receiving 5 mg/kg of bepridil demonstrated 
increases in the Wenckebach R-R interval for 45 
minutes following bepridil administration. 
Group comparisons revealed that the prolonga- 
tion of the Wenckebach R-R interval in animals 
anesthetized with enflurane was greater than 
q Halothane l p < .05 paired to baseline 
l * p < .02 paired to baseline 
() Enflurane l *’ p < .Ol paired to baseline 
n Chloralosa + p < .05 Student t compared to chbratose 
++ p < .02 student t axnpared to chloraklse 
0 lsofiurane +++ p < .Ol Student t compared to chloralose 
All values Msec f S.D. 
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Time (minutes) 
Fig 3. Serial changes in atrial-His intervals (160 beats/min) (mean values f SD) show efFect of beprklil (5 mglkg). 
Values represent changes from control values at 5,15,30.45, and SO minutes following bepridil edmiiration. 
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** p < .02 paired to baseline 
l *’ p < .Ol paired to baseline 
+ p < .05 Student t compered to chlorabse 
++ p < .02 Student t compsred to chbra?ase 
+++ p < .Ol Student t compared to chlorabse 
Ail values Msec f SD. 
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Fig 4. Serial changes in Wenckebach R-R intervals (mean values r SD) show effect of bepridil (5 mg/kg) V&ues 
represent changes from control values 5,15,30,45, and 60 minutes following bepridil administration. 
that observed in animals anesthetized with chlo- 
ralose, halothane, or isoflurane following admin- 
istration of bepridil, 5 mg/kg, (P -C .Ol) (Fig 4). 
Values obtained prior to bepridil administration 
were not different when anesthetic groups were 
compared (chloralose 250 f 30 ms, halothane 
290 + 40 ms, isoflurane 260 + 30 ms, enflurane 
280 f 40 ms). 
Atria1 effective refractory period was 
increased in all animals following administration 
of 5 mg/kg of bepridil (Table 3). The increase 
observed in the group of animals anesthetized 
with enflurane was greater than those observed 
in the groups of animals anesthetized with chlo- 
ralose, halothane, or isoflurane. 
Ventricular effective refractory period was 
unchanged in all groups following 2.5 mg/‘kg of 
bepridil, while this measurement was proloaged 
in all groups following 5 mg/kg of bepridil. 
There were no group differences in bepriciil’s 
Table 3. Bepridil(5 mg/kg) Effects on Atrial Effective Refractory Periods Reported as Increase From &e&ii Valuea 
-.. -.-.-_-- 
AlMSthNiC 5 min 15 min 30 min 45 min 60 mm 
-.. 
Chloralosa 36 f 11’ 19 f 6t 17 + 5t 18 k 9 1’7 + 9 
Halothane 37 -c_ 14, 33 + 19 34 I 12f 40~~ 18 27 f 1~3 
Enflurane 109 -t 30t* 86 f 22tS 91 + 24t§ 69 rt 22t/j JO t I@$ 
lsoflurane 27 k 19’ 22 k 16 26 i 22* 13 i 22 22 t 13 
-.. - ---... .-_ .-- 
NOTE. All values are in ms + SD. 
‘P c: .05 paired to baseline. 
tP c: .O 1 paired to baseline. 
$P < .02 Student’s t compared to chloralose. 
&’ < .Ol Student’s t compared to chloralose. 
I/P c .05 Student’s t compared to chloralose. 
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Table 4. Bepridil(6 mglkg) Effects on Ventricular Effective Refractory Periods Reported as Increase From Baseline Values 
Anesthetic 5 min 15 min 30 min 45 min 60 min 
Chloralose 40 f 8 37 2 8 36 k 6 34 + 8 24 + 10 
Halothane 33 + 16 30 + 20 16 f 13 20+ 10 20 + 9 
Enflurane 36 + 26 40 A 25 18 + 17 49 + 13 40 + 6 
lsoflurane 35* 11 32+ 13 24 r 9 21 * 10 20 + 8 
NOTE. All values are in ms + SD. 
effects on ventricular effective refractory period 
(Table 4). 
Plasma concentrations of bepridil in the 
groups were not different following either dose 
during anesthesia with any of the anesthetics 
tested (Tables 5 and 6). Bepridil concentrations 
fell rapidly immediately after infusion of both 
doses of bepridil. The decline in plasma concen- 
trations became slower thereafter. This drop in 
plasma bepridil levels is not inconsistent with the 
drug’s long half-life, for it is unlikely that the 
linear portion of the elimination curve was 
reached during the course of the experiment. 
for this class of drugs.‘,* Its apparent ability to 
prevent reperfusion tachydysrhythmias and ven- 
tricular fibrillation’ make it an even more attrac- 
tive drug to the research scientist and perhaps 
ultimately to the practicing physician. Impor- 
tantly, bepridil serum levels persist in patients for 
increased periods following its discontinuance 
because of its prolonged half-life. Therefore, the 
potential for interactions with volatile anesthetic 
agents also persists despite discontinuance of the 
drug. 
Intravenous administration of 40 mL of 5% 
ethanol, the solvent in which bepridil is dissolved, 
had no effect on any measurement at any time 
during the 60-minute observation period. 
DISCUSSION 
The cardiac electrophysiologic interactions 
between the volatile anesthetics and various cal- 
cium antagonists have been previously investi- 
gated. Significant abnormalities in both SA and 
AV nodal functions have been reported in dogs 
anesthetized with the volatile anesthetics and 
given verapamil.*‘**’ During isoflurane anes- 
thesia, dogs receiving diltiazem have demon- 
strated sinus node arrest with junctional escape 
rhythms,22.23 while in one series second-degree 
heart block was also demonstrated. 
Sassine et al,” investigating the cardiac 
electrophysiologic effects of IV-administered 
bepridil in dogs anesthetized with pentobarbital, 
reported a decrease in sinus heart rate, a prolon- 
gation of sinoatrial node recovery time, an 
increase in atria1 refractory period, a slowing of 
AV nodal conduction and an increase in AV 
nodal refractoriness, and a lengthening of 
Wenckebach periodicity. Singh et a1,4 studying 
the cardiac electrophysiologic effects of IV- 
administered bepridil in unanesthetized humans, 
reported a decrease in sinus heart rate, an 
increase in the AH bundle interval, and an 
increase in the refractory period of the atrial- 
ventricular node with a lengthening of the 
Wenckebach periodicity. These studies have 
demonstrated the electrophysiologic effects of 
bepridil alone and in combination with barbitu- 
rates. Interactions of bepridil with volatile anes- 
thetics have not been addressed.4*17 
Bepridil is a unique addition to the group of In this study, sinus node function was 
calcium antagonists. Its long half-life, as well as assessed by three measurements: spontaneous 
its fast sodium channel blocking and antidys- heart rate, CSNRT, and SACT. Changes in 
rhythmic properties, may expand the indications spontaneous heart rate reflect a combination of 
Table 5. Serum Concentrations in ng/mL Following Bepridil, 2.6 mglkg 
Anesthetic 5 min 
Chloralose 700 + 330 
Halothane 800 + 190 
Enflurane 1,120 + 520 
lsoflurane 670 f 310 
NOTE. Values are means f SD. 
15 min 30 min 45 min 60 min 
480 + 220 340 f 160 240+ 110 190 f 100 
470 + 140 370 f 100 310 f 110 260 + SO 
1,000 + 520 800 + 440 590 f 350 510 + 320 
440 + 250 340 2 210 240 f 160 270 + 220 




Table 6. Serum Concentrations in ng/mL Following Bepridil, 6.0 mg/kg 
5 min 15 min 30 min 45 min 
-.^-..-_ -_- 
60 rrtn 
--._ __ -.- 
Chloralose 1.370 rt 660 1,060 + 560 
Halothane 1,770 + 500 1,310 f 390 
Enflurane 2,040 + 770 1.190 r 500 
lsoflurane 2,050 * 730 1,400 + 410 
-.. 
NOTE. Values are means + SD. 
the direct and indirect autonomic effects of 
bepridil. Bepridil decreased heart rate in all 
groups during the observation period. These 
results are consistent with those obtained in 
animals anesthetized with pentobarbital and 
w&h data obtained in clinical trials.4*‘9 
Corrected sinus node recovery time, once 
thought to be strictly a reflection of sinus node 
automaticity, is now the most widely used mea- 
surement of sinus node function.24 The mecha- 
nism of prolongation of the CSNRT is of uncer- 
tail1 etiology, although an abnormally prolonged 
CSYRT does occur secondary to sinoatrial exit 
blcxk.25 SACT was measured to elucidate the 
mechanism for the prolongation of CSNRT. All 
animals had CSNRT of less than 500 ms at the 
control measurement. Sinoatrial conduction time 
did not increase following either 2.5 or 5 mg/kg 
of bepridil in animals anesthetized with chlo- 
ralose, halothane, or isoflurane. In contrast, 
markedly prolonged CSNRT of greater than 
three seconds occurred in four of seven animals 
rec;eiving 5 mg/kg of bepridil during enflurane 
anesthesia. Two of the four animals in the enflu- 
rane group had prolonged SACT following the 
administration of 5.0 mg/kg of bepridil, while 
the other two animals did not. This suggests that 
sinoatrial conduction is important in explaining 
some, but not all, of the long sinus pauses follow- 
ing rapid atria1 pacing. It is likely that the delay 
in CSNRT in the two animals with abnormal 
SACT was due to delay in the conduction of 
impulses out of the sinus node, ie, sinoatrial exit 
block. The other two animals in the enflurane 
and 5.0 mg/kg of bepridil group had prolonged 
CSXRT while demonstrating no abnormality in 
sinoatrial conduction, suggesting that depression 
of sinus node automaticity was the probable 
cause of prolongation of CSNRT in these two 
animals. 
The effect of bepridil on atrioventricular 
nodal function was determined by assessment of 
the AH interval (at 150 bpm) and the Wencke- 
- 
840 t 560 680 f 410 560 + 330 
1,120 + 420 940 + 350 870 + 390 
850 + 370 690 + 320 580 + 240 
1,040 + 290 880 + 320 730 i 200 
bath R-R interval. The atria1 His-bundle in:er- 
val at 150 bpm is a measure of the conduct ion 
time through the AV node at this rate. ‘t’he 
Wenckebach R-R interval correlates with the 
atrioventricular node effective refractory pcri- 
od.26 At the 2.5 mg/kg dose, the depressLInt 
effects of bepridil on A-V nodal function were 
similar in all anesthetized animals. Drug- 
induced increases in refractoriness were ;;vi- 
dented by the occurrence of Wenckebach phe- 
nomenon at slower heart rates. Atriai-t-Iis 
intervals at a rate of 150 bpm were largely 
unaffected in any anesthetic group at this &SC.: of 
bepridil. When bepridil, 5 mg/kg, was admiilis- 
tered, there were significant increases in cortduc- 
tion times and refractoriness of the A-V node- in 
all anesthetic groups. The bepridil-indu::ed 
increases were larger, however, in the anrmals 
anesthetized with enflurane. Although the A-V 
nodal depressant effects of bepridil were greuter 
during enflurane anesthesia than during cblo- 
ralose, halothane, or isoflurane anesthesia, these 
effects were more uniform than the depressant 
effects on the parameters of S-A node fun&ton, 
The potentially catastrophic depression oi‘ the 
S-A node was not noted in the depressant efft:cts 
on the A-V node. No animal evidenced qponta- 
neous second- or third-degree heart block. 
The atria1 effective refractory period was 
increased in animals receiving 5 mgikg of 
bepridil and anesthetized with enflurane wiien 
compared to animals anesthetized with chlora- 
lose, halothane, or isoflurane. Bepridil, 5 mgjkg, 
produced prolongation of the ventricular zffec- 
tive refractory period for 45 minutes of‘ ihe 
observation period in animals anesthetized with 
chloralose and halothane, and for 60 minutes in 
animals anesthetized with enflurane and isoBu- 
rane. These results are consistent with those of 
Sassine et al, who demonstrated a greater profon- 
gation of the atria1 effective refractory period 
than of the ventricular effective refractor!. period 
in animals anesthetized with pentobarbita 1 :i nd 
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receiving 5 mg/kg of bepridil.” In that study, 
bepridil prolonged atria1 refractory period with a 
minimal effect on the duration of the atria1 
monophasic action potential.” 
Serum bepridil levels at all measurement 
time periods and both dosages were comparable 
to those reported in both human volunteers and 
in patients treated with bepridil for angina in 
doses ranging from 200 mg to 600 mg orally 
(PO), daily.5 Although Sassine et al” did not 
report serum levels in their canine study, the IV 
bepridil doses used in this study are comparable 
to those used in their study. Their results in 
pentobarbital-anesthetized dogs are comparable 
to the present chloralose-anesthetized animals.” 
At the 5-mg/kg dose of bepridil, depression 
of sinus and atrioventricular nodal conduction 
and of atria1 refractoriness were of greater mag- 
nitude and duration in animals anesthetized with 
enflurane than in animals anesthetized with 
chloralose, halothane, or isoflurane. This sug- 
gests that in the presence of enflurane bepridil 
inhibits slow calcium fluxes to a greater extent 
than in animals anesthetized with chloralose, 
halothane, or isoflurane. Consistent with this 
observation is the finding that the atria1 effective 
refractory period is increased in animals receiv- 
ing enflurane, suggesting that the inhibition of 
the calcium fluxes could be secondary to a 
delayed reactivation of the calcium channel.” 
present in this experiment following rapid atria1 
pacing. In addition, one enflurane-anesthetized 
animal demonstrated a SACT greater than 3.5 
seconds (ie, a pause following pacing at a rate 
just greater than spontaneous heart rate), sug- 
gesting the existence of a potential for a severe 
bradyarrhythmia following the use of enflurane 
in patients taking bepridil in the absence of a 
history of supraventricular tachycardia. This 
suggests that caution should be used in the use of 
enflurane in patients receiving bepridil. Depres- 
sant effects on the atrioventricular node could 
not be demonstrated at the 2.5-mg/kg dose of 
bepridil (ie, no therapeutic effects were evident 
at this dose in dogs). A-V nodal depression was 
noted at the 5-mg/kg dose, which strongly sug- 
gests that this is an appropriate dose for study of 
this drug in dogs. 
The combination of bepridil, 5.0 mg/kg, 
and enflurane, 3.3% (MAC = 2.2%), caused 
severe sinus node dysfunction as measured by 
CSNRT. Since one of the potential clinical uses 
of bepridil is the treatment of supraventricular 
tachycardia, patients with a history of paroxys- 
mal supraventricular tachycardia may be sched- 
uled for surgery while receiving bepridil. The 
combination of enflurane and an episode of 
supraventricular tachycardia in these patients 
could result in conditions analogous to those 
In summary, these data clearly demon- 
strate that the calcium-blocking actions of 
bepridil are more pronounced during enflurane 
anesthesia than during chloralose, halothane, or 
isoflurane anesthesia in dogs. Following the IV 
administration of 5 mg/kg of bepridil, severe 
sinus node dysfunction occurred in half of the 
animals anesthetized with enflurane. This was 
demonstrated both by prolonged CSNRT and by 
prolonged SACT. In at least two cases, the 
abnormal sinus node function was presumably 
due to sinoatrial node exit block. Atrioventricu- 
lar nodal function is depressed more by bepridil 
in animals anesthetized with enflurane than in 
animals anesthetized with halothane, isoflurane, 
or chloralose. No spontaneous second- or third- 
degree heart block was demonstrated, however, 
following either dose of bepridil with any of the 
anesthetic agents. In addition, if the pacing func- 
tion of the sinus node is inhibited, other pace- 
makers in the atrioventricular junction cannot be 
relied upon to maintain heart rate since they are 
depressed by inhalational anesthetics.27 
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